COVID‐19 vaccine (mRNA BNT162b2) and COVID‐19 infection‐induced thrombotic thrombocytopenic purpura in adolescents

The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID‐19 vaccination or infection in pediatric or adolescent patient...

Full description

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 69; no. 6; pp. e29681 - n/a
Main Authors Vorster, Luna, Kirk, Susan E., Muscal, Eyal, Despotovic, Jenny M., Cohen, Clay T., Sartain, Sarah E.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.06.2022
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID‐19 vaccination or infection in pediatric or adolescent patients. We describe three adolescents presenting with TTP (both de novo and relapsed disease) following administration of the Pfizer COVID‐19 vaccine or after COVID‐19 infection. Our observations demonstrate that the Pfizer‐BioNTech mRNA vaccine and COVID‐19 infection can act as triggers for the development/relapse of both congenital and acquired TTP.
AbstractList The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID‐19 vaccination or infection in pediatric or adolescent patients. We describe three adolescents presenting with TTP (both de novo and relapsed disease) following administration of the Pfizer COVID‐19 vaccine or after COVID‐19 infection. Our observations demonstrate that the Pfizer‐BioNTech mRNA vaccine and COVID‐19 infection can act as triggers for the development/relapse of both congenital and acquired TTP.
Abstract The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID‐19 vaccination or infection in pediatric or adolescent patients. We describe three adolescents presenting with TTP (both de novo and relapsed disease) following administration of the Pfizer COVID‐19 vaccine or after COVID‐19 infection. Our observations demonstrate that the Pfizer‐BioNTech mRNA vaccine and COVID‐19 infection can act as triggers for the development/relapse of both congenital and acquired TTP.
Author Muscal, Eyal
Cohen, Clay T.
Vorster, Luna
Sartain, Sarah E.
Kirk, Susan E.
Despotovic, Jenny M.
AuthorAffiliation 1 Department of Pediatrics, Baylor College of Medicine Texas Children's Hospital Houston Texas USA
3 Department of Pediatrics, Section of Rheumatology, Baylor College of Medicine Texas Children's Hospital Houston TX USA
4 Department of Pediatrics, Section of Neurology/Developmental Neuroscience, Baylor College of Medicine Texas Children's Hospital Houston TX USA
2 Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine Texas Children's Hospital Houston TX USA
AuthorAffiliation_xml – name: 1 Department of Pediatrics, Baylor College of Medicine Texas Children's Hospital Houston Texas USA
– name: 4 Department of Pediatrics, Section of Neurology/Developmental Neuroscience, Baylor College of Medicine Texas Children's Hospital Houston TX USA
– name: 3 Department of Pediatrics, Section of Rheumatology, Baylor College of Medicine Texas Children's Hospital Houston TX USA
– name: 2 Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine Texas Children's Hospital Houston TX USA
Author_xml – sequence: 1
  givenname: Luna
  surname: Vorster
  fullname: Vorster, Luna
  organization: Texas Children's Hospital
– sequence: 2
  givenname: Susan E.
  surname: Kirk
  fullname: Kirk, Susan E.
  organization: Texas Children's Hospital
– sequence: 3
  givenname: Eyal
  surname: Muscal
  fullname: Muscal, Eyal
  organization: Texas Children's Hospital
– sequence: 4
  givenname: Jenny M.
  orcidid: 0000-0001-9569-3636
  surname: Despotovic
  fullname: Despotovic, Jenny M.
  organization: Texas Children's Hospital
– sequence: 5
  givenname: Clay T.
  orcidid: 0000-0001-6819-4049
  surname: Cohen
  fullname: Cohen, Clay T.
  organization: Texas Children's Hospital
– sequence: 6
  givenname: Sarah E.
  orcidid: 0000-0003-2204-4568
  surname: Sartain
  fullname: Sartain, Sarah E.
  email: sartain@bcm.edu
  organization: Texas Children's Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35373880$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1KAzEUhYMo_i98ARlwYxfVZDKZTjZCW3-hVBF1G5LMHZvSJmNmptqdj-Az-iRGq0UXQiD3Jt8998DZQqvWWUBoj-AjgnF8XCp9FPM0Iytok7CEtRkmndVljfkG2qqqcUBTzLJ1tEEZ7dAsw5vopX_9cHX6_vpGeDSTWhsL0eH0dtiNesM7ksYqbkXS5tEvzNgCdG2cDa2xeaMhj-qRd1PlaqN_Sj2vXQk2PJSND0eGuUjmbgKVBltXO2itkJMKdr_vbXR_fnbXv2wPri-u-t1BWweLpM01JhpDClRnaZ5I4JKrhCjdoYzjggTLtMgSrguVKhUzJimmCvIYklxD6LbRyUK3bNQU8s_dXk5E6c1U-rlw0oi_P9aMxKObCY6zjKadIHDwLeDdUwNVLcau8TZ4FnHKKKeEYhao1oLS3lWVh2K5gWDxGZIIIYmvkAK7_9vSkvxJJQDHC-DZTGD-v5K46fUXkh83laEP
CitedBy_id crossref_primary_10_1002_pbc_29749
crossref_primary_10_1016_j_phoj_2024_01_003
crossref_primary_10_1002_pbc_30051
crossref_primary_10_3390_biomedicines12030621
crossref_primary_10_1002_jmv_28946
crossref_primary_10_3390_diagnostics13071228
crossref_primary_10_1007_s11684_023_1054_2
crossref_primary_10_1007_s40278_022_19016_y
Cites_doi 10.1097/BOR.0000000000000776
10.1016/j.clim.2020.108480
10.1111/jth.15418
10.1002/ajh.23527
10.1016/j.transci.2021.103145
10.1016/j.jocn.2020.04.062
10.1172/JCI26007
10.1097/MPH.0b013e3182755c38
10.1016/j.autrev.2020.102524
10.1002/ajh.22091
10.3324/haematol.13524
10.3324/haematol.2008.002493
10.1002/ajh.26132
10.1007/s12185-021-03190-y
10.1182/blood.2021011548
10.1016/j.jaut.2021.102663
10.1111/bjh.17645
10.2169/internalmedicine.49.2957
10.1016/j.clim.2021.108665
10.1016/j.ajem.2021.05.054
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC
2022 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC
– notice: 2022 Wiley Periodicals LLC.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TO
8FD
FR3
H94
K9.
P64
RC3
5PM
DOI 10.1002/pbc.29681
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
Genetics Abstracts
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate VORSTER et al
EISSN 1545-5017
EndPage n/a
ExternalDocumentID 10_1002_pbc_29681
35373880
PBC29681
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OC
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
UB1
UDS
V2E
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XV2
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TO
8FD
FR3
H94
K9.
P64
RC3
5PM
ID FETCH-LOGICAL-c3731-9c01c0e6e3c86d4ae9a9b41bc73590f1acc3f849cfb6bb255a303bed2e4dce5a3
IEDL.DBID DR2
ISSN 1545-5009
IngestDate Tue Sep 17 21:27:49 EDT 2024
Thu Oct 10 20:22:40 EDT 2024
Fri Aug 23 02:13:00 EDT 2024
Thu Oct 24 09:23:53 EDT 2024
Sat Aug 24 00:55:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
acquired TTP
TTP
vaccination
Language English
License 2022 Wiley Periodicals LLC.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3731-9c01c0e6e3c86d4ae9a9b41bc73590f1acc3f849cfb6bb255a303bed2e4dce5a3
ORCID 0000-0001-6819-4049
0000-0001-9569-3636
0000-0003-2204-4568
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9088367
PMID 35373880
PQID 2653931305
PQPubID 1036357
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9088367
proquest_journals_2653931305
crossref_primary_10_1002_pbc_29681
pubmed_primary_35373880
wiley_primary_10_1002_pbc_29681_PBC29681
PublicationCentury 2000
PublicationDate June 2022
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Glenview
– name: Hoboken
PublicationTitle Pediatric blood & cancer
PublicationTitleAlternate Pediatr Blood Cancer
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2021; 13
2021; 49
2010; 49
2021; 33
2013; 88
2013; 35
2009; 94
2021; 137
2021; 114
2021; 224
2021; 138
2005; 115
2021; 19
2011; 86
2021; 195
2020; 217
2021; 121
2020; 76
2021; 60
2021; 96
2020; 19
35484992 - Pediatr Blood Cancer. 2022 Dec;69(12):e29749
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
Shankar K (e_1_2_6_12_1) 2021; 13
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
Paulsen FO (e_1_2_6_10_1) 2021; 138
e_1_2_6_14_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 96
  start-page: 534
  year: 2021
  end-page: 537
  article-title: Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
  publication-title: Am J Hematol
– volume: 49
  start-page: 689
  issue: 7
  year: 2010
  end-page: 693
  article-title: Influenza a infection triggers thrombotic thrombocytopenic purpura by producing the anti‐ADAMTS13 IgG inhibitor
  publication-title: Intern Med
– volume: 35
  start-page: 551
  issue: 7
  year: 2013
  end-page: 553
  article-title: Successful treatment of congenital TTP with a novel approach using plasma‐derived factor VIII
  publication-title: J Pediatr Hematol Oncol
– volume: 195
  start-page: 365
  issue: 3
  year: 2021
  end-page: 370
  article-title: Exacerbation of immune thrombocytopenia following COVID‐19 vaccination
  publication-title: Br J Haematol
– volume: 115
  start-page: 2752
  issue: 10
  year: 2005
  end-page: 2761
  article-title: Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13‐deficient mice
  publication-title: J Clin Invest
– volume: 94
  start-page: 166
  issue: 2
  year: 2009
  end-page: 170
  article-title: Inherited thrombotic thrombocytopenic purpura
  publication-title: Haematologica
– volume: 88
  start-page: 895
  issue: 10
  year: 2013
  end-page: 898
  article-title: ADAMTS13 content in plasma‐derived factor VIII/von Willebrand factor concentrates
  publication-title: Am J Hematol
– volume: 19
  start-page: 2014
  year: 2021
  end-page: 2018
  article-title: First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination
  publication-title: J Thromb Haemost
– volume: 224
  year: 2021
  article-title: Do COVID‐19 RNA‐based vaccines put at risk of immune‐mediated diseases? In reply to “potential antigenic cross‐reactivity between SARS‐CoV‐2 and human tissue with a possible link to an increase in autoimmune diseases”
  publication-title: Clin Immunol
– volume: 33
  start-page: 155
  year: 2021
  end-page: 162
  article-title: COVID‐19 and autoimmune diseases
  publication-title: Curr Opin Rheumatol
– volume: 19
  issue: 5
  year: 2020
  article-title: Could Sars‐coronavirus‐2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects
  publication-title: Autoimmun Rev
– volume: 94
  start-page: 289
  issue: 2
  year: 2009
  end-page: 293
  article-title: The first deletion mutation in the TSP1‐6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura
  publication-title: Haematologica
– volume: 114
  start-page: 626
  issue: 5
  year: 2021
  end-page: 629
  article-title: Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
  publication-title: Int J Hematol
– volume: 137
  start-page: 3670
  issue: 26
  year: 2021
  end-page: 3673
  article-title: COVID‐19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
  publication-title: Blood
– volume: 217
  year: 2020
  article-title: Potential antigenic cross‐reactivity between SARS‐CoV‐2 and human tissue with a possible link to an increase in autoimmune diseases. [letter]
  publication-title: Clin Immunol
– volume: 13
  issue: 7
  year: 2021
  article-title: A case of COVID‐19 induced thrombotic thrombocytopenic purpura
  publication-title: Cureus
– volume: 76
  start-page: 233
  year: 2020
  end-page: 235
  article-title: Guillain Barre syndrome associated with COVID‐19 infection: a case report
  publication-title: J Clin Neurosci
– volume: 49
  start-page: 58
  year: 2021
  end-page: 61
  article-title: Thrombosis with thrombocytopenia syndrome associated with COVID‐19 vaccines
  publication-title: Am J Emerg Med
– volume: 138
  start-page: 996
  issue: 11
  year: 2021
  end-page: 999
  article-title: Immune thrombocytopenic purpura after vaccination with COVID‐19 vaccine (ChAdOx1 nCov‐19)
  publication-title: Blood
– volume: 121
  year: 2021
  article-title: Perspectives on vaccine induced thrombotic thrombocytopenia
  publication-title: J Autoimmun
– volume: 86
  start-page: 743
  issue: 9
  year: 2011
  end-page: 751
  article-title: Systemic infections mimicking thrombotic thrombocytopenic purpura
  publication-title: Am J Hematol
– volume: 60
  year: 2021
  article-title: Relapse of thrombotic thrombocytopenic purpura after COVID‐19 vaccine
  publication-title: Transfusion and Apheresis Science
– ident: e_1_2_6_14_1
  doi: 10.1097/BOR.0000000000000776
– ident: e_1_2_6_22_1
  doi: 10.1016/j.clim.2020.108480
– ident: e_1_2_6_4_1
  doi: 10.1111/jth.15418
– ident: e_1_2_6_2_1
  doi: 10.1002/ajh.23527
– ident: e_1_2_6_5_1
  doi: 10.1016/j.transci.2021.103145
– ident: e_1_2_6_15_1
  doi: 10.1016/j.jocn.2020.04.062
– ident: e_1_2_6_24_1
– ident: e_1_2_6_19_1
  doi: 10.1172/JCI26007
– ident: e_1_2_6_3_1
  doi: 10.1097/MPH.0b013e3182755c38
– ident: e_1_2_6_21_1
  doi: 10.1016/j.autrev.2020.102524
– ident: e_1_2_6_16_1
  doi: 10.1002/ajh.22091
– ident: e_1_2_6_18_1
  doi: 10.3324/haematol.13524
– ident: e_1_2_6_17_1
  doi: 10.3324/haematol.2008.002493
– volume: 13
  issue: 7
  year: 2021
  ident: e_1_2_6_12_1
  article-title: A case of COVID‐19 induced thrombotic thrombocytopenic purpura
  publication-title: Cureus
  contributor:
    fullname: Shankar K
– ident: e_1_2_6_8_1
  doi: 10.1002/ajh.26132
– ident: e_1_2_6_11_1
  doi: 10.1007/s12185-021-03190-y
– ident: e_1_2_6_23_1
  doi: 10.1182/blood.2021011548
– ident: e_1_2_6_7_1
  doi: 10.1016/j.jaut.2021.102663
– ident: e_1_2_6_9_1
  doi: 10.1111/bjh.17645
– ident: e_1_2_6_13_1
  doi: 10.2169/internalmedicine.49.2957
– ident: e_1_2_6_20_1
  doi: 10.1016/j.clim.2021.108665
– ident: e_1_2_6_6_1
  doi: 10.1016/j.ajem.2021.05.054
– volume: 138
  start-page: 996
  issue: 11
  year: 2021
  ident: e_1_2_6_10_1
  article-title: Immune thrombocytopenic purpura after vaccination with COVID‐19 vaccine (ChAdOx1 nCov‐19)
  publication-title: Blood
  contributor:
    fullname: Paulsen FO
SSID ssj0026058
Score 2.428403
Snippet The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic...
The mRNA COVID-19 vaccine and COVID-19 infection caused by the SARS-CoV-2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic...
Abstract The mRNA COVID‐19 vaccine and COVID‐19 infection caused by the SARS‐CoV‐2 virus may be immunologic triggers for the development of thrombotic...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e29681
SubjectTerms acquired TTP
Adolescent
Adolescents
BNT162 Vaccine
Child
COVID-19
COVID-19 - complications
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
Hematology
Hematology: Brief Report
Hematology: Brief Reports
Humans
Infections
mRNA
mRNA Vaccines
Oncology
Pediatrics
Purpura
Purpura, Thrombotic Thrombocytopenic - genetics
RNA, Messenger - genetics
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Teenagers
Thrombocytopenic purpura
Thrombotic thrombocytopenic purpura
TTP
Vaccination
Vaccines
Vaccines, Synthetic
Title COVID‐19 vaccine (mRNA BNT162b2) and COVID‐19 infection‐induced thrombotic thrombocytopenic purpura in adolescents
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpbc.29681
https://www.ncbi.nlm.nih.gov/pubmed/35373880
https://www.proquest.com/docview/2653931305
https://pubmed.ncbi.nlm.nih.gov/PMC9088367
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7Eg3jx_agvgnjQQ9c2bdMNnnRVVHAVUfEglCRNUWTroruinvwJ_kZ_iZN0W3cVQbwladKmM0nnSzrzBWBNpmjkufJc7inp4ggRrohU7MZUUpZmGiGsCXA-brKDi_DoKroagq0yFqbgh6g23MzMsN9rM8GFfNz8Ig1tS1WjnNmwa0OkZwDRWUUdZWC6DYNDhOBGCCRKViGPblYtB23RD4D500-yH79aA7Q_Dtdl1wu_k7tatyNr6vUbq-M_320CxnrAlGwXI2kShnQ-BSPHvV_v0_DcOLk83P14e_c5eRLKFJL11llzm-w0z32GQt8gIk9JX7XS0SvHLC79cRClxBzL0JL3-JAyqV465ggvLGij0rsPAtuRPqKpGbjY3ztvHLi9YxtcFcSB76LmfeVppgNVZ2koNBdchr5UcRBxL_Oxi0FWD7nKJJMSlzQCzajUKdUhShpzszCc3-d6HkhY11zRLE6lMHylmUC0puI0VIanninmwGqpwKRdsHMkBQ8zTVCGiZWhA0ulapPeBH1MqKHkDdCARw7MFVqu7hBEhu6p7jkQD-i_qmAouQev5Lc3lprbeI0FLHZg3ar3904lpzsNm1j4e9VFGKUm-MLuAS3BcOehq5cREnXkih37n1EbCw8
link.rule.ids 230,315,786,790,891,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9swED8hJm17Yf9gy8aGhfbAHtImTuLU0l6gDJVBuwkVxAuKbMcRCBEq1k7bnvYR9hn3SXbnNKEFIaG92Y6dOHe-3M-O72eA9zpHJy9N4MvAaB9HiPJVYlI_5ZqLvLAIYSnAuT8QvcP483FyvAAf61iYih-iWXAjy3DfazJwWpBuX7OGjrRpcSko7voBmntCZrl90JBHEVB3gXCIEfwEoUTNKxTwdtN03hvdgpi3d0rOIljngnaewEnd-WrnyXlrMtYt8-sGr-P_vt1TWJpiU7ZZDaZnsGDL5_CwP_37_gJ-dL8c7W7__f0nlOy7MlTINi4OBptsazAMBcr9A1Nlzmaq1Xu9Sszi7B_HUc7oZIYLfYkPqZPm55hO8cKCEep9cqWwHZvhmlqGw51Pw27Pn57c4JsojUIflR-awAobmY7IY2WlkjoOtUmjRAZFiF2Mik4sTaGF1jirUehJtc25jVHUmFuBxfKytK-AxR0rDS_SXCuiLC0UAjaT5rEhqnphhAfrtQazUUXQkVVUzDxDGWZOhh6s1rrNpjb6LePEyhuhD088eFmpublDlBDjUyfwIJ0bAE0FYuWev1KenTp2bto4FonUgw2n37s7lX3d6rrE6_tXXYNHvWF_P9vfHey9gcecYjHcktAqLI6vJvYtIqSxfucM4R_xvQ8v
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hKqFe6IMCobS1EAd6yJLYibNWT7DbFc8tQoA4IEV-Ra2qDSvYrdqe-hP6G_tLOnY26W4REuJmO3bizNiZz87MZ4BNZdDICx2FItIqxBEiQ5nqLMyootwUFiGsC3A-7vO98-TgMr2cgw91LEzFD9FsuLmZ4b_XboIPTbH9jzR0qHSLCu7Crp8knFG38uqeNtxRDqf7ODiECGGKSKKmFYrodtN01hjdQZh3HSWnAay3QL1ncFX3vXI8-doaj1RL__yP1vGRL_ccFifIlOxUQ-kFzNnyJSwcT_69L8H3zqeL_e6fX79jQb5J7QrJ1uC0v0N2-2cxR6m_J7I0ZKpa7elVYhbX_jiKDHHnMgzUNT6kTuofI3eGFxYMUevjG4ntyBTT1Cs473086-yFk3MbQs0yFoeo-lhHllum29wk0gopVBIrnbFUREWMXWRFOxG6UFwpXNNItKPKGmoTlDTmlmG-vC7tKpCkbYWmRWaUdISlhUS4pjOTaEdUzzUPYKNWYD6s6DnyioiZ5ijD3MswgPVatflkht7m1HHyMrTgaQArlZabO7DU8T21owCyGf03FRwn9-yV8stnz83t3MYYzwLY8uq9v1P5yW7HJ9YeXvUdLJx0e_nRfv_wNTylLhDD7wetw_zoZmzfIDwaqbd-GvwFyaoN3g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID%E2%80%9019+vaccine+%28mRNA+BNT162b2%29+and+COVID%E2%80%9019+infection%E2%80%90induced+thrombotic+thrombocytopenic+purpura+in+adolescents&rft.jtitle=Pediatric+blood+%26+cancer&rft.au=Vorster%2C+Luna&rft.au=Kirk%2C+Susan+E.&rft.au=Muscal%2C+Eyal&rft.au=Despotovic%2C+Jenny+M.&rft.date=2022-06-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1545-5009&rft.eissn=1545-5017&rft.volume=69&rft.issue=6&rft_id=info:doi/10.1002%2Fpbc.29681&rft_id=info%3Apmid%2F35373880&rft.externalDBID=PMC9088367
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1545-5009&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1545-5009&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1545-5009&client=summon